The DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines
Open accessAbstract
Preclinical characterization of novel nanotechnology-based formulations is often challenged by physicochemical characteristics, sterility/sterilization issues, safety and efficacy. Such challenges are not unique to nanomedicine, as they are common in the development of small and macromolecular drugs. However, due to the lack of a general consensus on critical characterization parameters, a shortage of harmonized protocols to support testing, and the vast variety of engineered nanomaterials, the translation of nanomedicines into clinic is particularly complex. Understanding the immune compatibility of nanoformulations has been identified as one of the important factors in (pre)clinical development and requires reliable in vitro and in vivo immunotoxicity tests. The generally low sensitivity of standard in vivo toxicity tests to immunotoxicities, inter-species variability in the structure and function of the immune system, high costs and relatively low throughput of in vivo tests, and ethical concerns about animal use underscore the need for trustworthy in vitro assays. Here, we consider the correlations (or lack thereof) between in vitro and in vivo immunotoxicity tests as a means to identify useful in vitro assays. We review literature examples and case studies from the experience of the NCI Nanotechnology Characterization Lab, and highlight assays where predictability has been demonstrated for a variety of nanomaterials and assays with high potential for predictability in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origin and physiological roles of inflammation
Medzhitov, R. (2008) · Nature · doi:10.1038/nature07201 · Cited by 6,618
Oberdörster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., Ausman, K., Carter, J., Karn, B., Kreyling, W., Lai, D., et al. (2005) · Particle and Fibre Toxicology · doi:10.1186/1743-8977-2-8 · Cited by 2,134
Monopoli, M. P., Walczyk, D., Campbell, A., Elia, G., Lynch, I., Baldelli Bombelli, F., & Dawson, K. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja107583h · Cited by 1,835
Immunological properties of engineered nanomaterials
Dobrovolskaia, M. A., & McNeil, S. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.223 · Cited by 1,823
Self-citationDisease Tolerance as a Defense Strategy
Medzhitov, R., Schneider, D. S., & Soares, M. P. (2012) · Science · doi:10.1126/science.1214935 · Cited by 1,718
Malik, N., Wiwattanapatapee, R., Klopsch, R., Lorenz, K., Frey, H., Weener, J. W., Meijer, E. W., Paulus, W., & Duncan, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00246-1 · Cited by 1,227
Colloidal Gold: A Novel Nanoparticle Vector for Tumor Directed Drug Delivery
Paciotti, G. F., Myer, L., Weinreich, D., Goia, D., Pavel, N., McLaughlin, R. E., & Tamarkin, L. (2004) · Drug Delivery · doi:10.1080/10717540490433895 · Cited by 1,185
Minireview: Nanoparticles and the Immune System
Zolnik, B. S., González-Fernández, A., Sadrieh, N., & Dobrovolskaia, M. A. (2010) · Endocrinology · doi:10.1210/en.2009-1082 · Cited by 914
Self-citationMethod for Analysis of Nanoparticle Hemolytic Properties in Vitro
Dobrovolskaia, M. A., Clogston, J. D., Neun, B. W., Hall, J. B., Patri, A. K., & McNeil, S. E. (2008) · Nano Letters · doi:10.1021/nl0805615 · Cited by 716
Self-citationNanoparticle‐induced platelet aggregation and vascular thrombosis
Radomski, A., Jurasz, P., Alonso‐Escolano, D., Drews, M., Morandi, M., Malinski, T., & Radomski, M. W. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706386 · Cited by 636
Information processing during phagocytosis
Underhill, D. M., & Goodridge, H. S. (2012) · Nature Reviews Immunology · doi:10.1038/nri3244 · Cited by 616
A PEGylated dendritic nanoparticulate carrier of fluorouracil
Bhadra, D., Bhadra, S., Jain, S., & Jain, N. K. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00132-7 · Cited by 544
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
Nanoparticle Hydrophobicity Dictates Immune Response
Moyano, D. F., Goldsmith, M., Solfiell, D. J., Landesman-Milo, D., Miranda, O. R., Peer, D., & Rotello, V. M. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2108905 · Cited by 478
Wysowski, D. K., & Swartz, L. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.12.1363 · Cited by 471
Szebeni, J., Muggia, F., Gabizon, A., & Barenholz, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.017 · Cited by 423
Engineering Nano‐ and Microparticles to Tune Immunity
Moon, J. J., Huang, B., & Irvine, D. J. (2012) · Advanced Materials · doi:10.1002/adma.201200446 · Cited by 404
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Wilke, R. A., Lin, D. W., Roden, D. M., Watkins, P. B., Flockhart, D., Zineh, I., Giacomini, K. M., & Krauss, R. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2423 · Cited by 391
Designing the nanoparticle–biomolecule interface for “targeting and therapeutic delivery”
Mahon, E., Salvati, A., Baldelli Bombelli, F., Lynch, I., & Dawson, K. A. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.04.009 · Cited by 385
Evaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Self-citationUpdate on Macrophage Clearance of Inhaled Micro- and Nanoparticles
Geiser, M. (2010) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2009.0797 · Cited by 365
Roser, M., Fischer, D., & Kissel, T. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00038-1 · Cited by 357
Risk Assessment in Immunotoxicology II. Relationships between Immune and Host Resistance Tests
Luster, M. (1993) · Fundamental and Applied Toxicology · doi:10.1006/faat.1993.1074 · Cited by 327
Acute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge
Geys, J., Nemmar, A., Verbeken, E., Smolders, E., Ratoi, M., Hoylaerts, M. F., Nemery, B., & Hoet, P. H. M. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11566 · Cited by 291
Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting
Bhadra, D., Yadav, A. K., Bhadra, S., & Jain, N. K. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.01.026 · Cited by 280
Lu, S., Duffin, R., Poland, C., Daly, P., Murphy, F., Drost, E., MacNee, W., Stone, V., & Donaldson, K. (2009) · Environmental Health Perspectives · doi:10.1289/ehp.11811 · Cited by 274
Crist, R. M., Grossman, J. H., Patri, A. K., Stern, S. T., Dobrovolskaia, M. A., Adiseshaiah, P. P., Clogston, J. D., & McNeil, S. E. (2013) · Integrative Biology · doi:10.1039/c2ib20117h · Cited by 265
Self-citationSafety assessment of nanomaterials: Implications for nanomedicine
Nyström, A. M., & Fadeel, B. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.01.027 · Cited by 264
Safety and immunotoxicity assessment of immunomodulatory monoclonal antibodies
Brennan, F. R., Morton, L. D., Spindeldreher, S., Kiessling, A., Allenspach, R., Hey, A., Müller, P., Frings, W., & Sims, J. (2010) · mAbs · doi:10.4161/mabs.2.3.11782 · Cited by 250
Agrawal, P., Gupta, U., & Jain, N. K. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.04.004 · Cited by 241
Nanomaterial standards for efficacy and toxicity assessment
Adiseshaiah, P. P., Hall, J. B., & McNeil, S. E. (2010) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.66 · Cited by 238
Self-citationImmune system targeting by biodegradable nanoparticles for cancer vaccines
Silva, J. M., Videira, M., Gaspar, R., Préat, V., & Florindo, H. F. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.03.010 · Cited by 233
Dobrovolskaia, M. A., Patri, A. K., Simak, J., Hall, J. B., Semberova, J., De Paoli Lacerda, S. H., & McNeil, S. E. (2012) · Molecular Pharmaceutics · doi:10.1021/mp200463e · Cited by 223
Self-citationSzebeni, J., Bedőcs, P., Rozsnyay, Z., Weiszhár, Z., Urbanics, R., Rosivall, L., Cohen, R., Garbuzenko, O., Báthori, G., Tóth, M., et al. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.003 · Cited by 219
Cationic PAMAM Dendrimers Aggressively Initiate Blood Clot Formation
Jones, C. F., Campbell, R. A., Brooks, A. E., Assemi, S., Tadjiki, S., Thiagarajan, G., Mulcock, C., Weyrich, A. S., Brooks, B. D., Ghandehari, H., et al. (2012) · ACS Nano · doi:10.1021/nn303472r · Cited by 207
Szebeni, J., Alving, C. R., Rosivall, L., Bünger, R., Baranyi, L., Bedöcs, P., Tóth, M., & Barenholz, Y. (2007) · Journal of Liposome Research · doi:10.1080/08982100701375118 · Cited by 199
Asthana, A., Chauhan, A. S., Diwan, P. V., & Jain, N. K. (2005) · AAPS PharmSciTech · doi:10.1208/pt060367 · Cited by 190
Agashe, H. B., Dutta, T., Garg, M., & Jain, N. K. (2006) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.58.11.0010 · Cited by 185
Interactions of nanomaterials with the immune system
Hussain, S., Vanoirbeek, J., & Hoet, P. (2011) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.166 · Cited by 167
Size and surface charge significantly influence the toxicity of silica and dendritic nanoparticles
Greish, K., Thiagarajan, G., Herd, H., Price, R., Bauer, H., Hubbard, D., Burckle, A., Sadekar, S., Yu, T., Anwar, A., et al. (2012) · Nanotoxicology · doi:10.3109/17435390.2011.604442 · Cited by 166
Geary, R. S., Yu, R. Z., Watanabe, T., Henry, S. P., Hardee, G. E., Chappell, A., Matson, J., Sasmor, H., Cummins, L., & Levin, A. A. (2003) · Drug Metabolism and Disposition · doi:10.1124/dmd.31.11.1419 · Cited by 162
Capture of Stealth Nanoparticles by the Body’s Defences
Moghimi, S. M., & Hunter, A. C. (2001) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v18.i6.30 · Cited by 154
Henry, S. P., Beattie, G., Yeh, G., Chappel, A., Giclas, P. C., Mortari, A., Jagels, M. A., Kornbrust, D. J., & Levin, A. A. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00142-x · Cited by 151
Jun, E.-A., Lim, K., Kim, K., Bae, O., Noh, J.-Y., Chung, K.-H., & Chung, J. (2010) · Nanotoxicology · doi:10.3109/17435390.2010.506250 · Cited by 149
Bihari, P., Holzer, M., Praetner, M., Fent, J., Lerchenberger, M., Reichel, C. A., Rehberg, M., Lakatos, S., & Krombach, F. (2009) · Toxicology · doi:10.1016/j.tox.2009.08.011 · Cited by 148
Gaucher, G., Asahina, K., Wang, J., & Leroux, J. (2009) · Biomacromolecules · doi:10.1021/bm801178f · Cited by 148
Progress in understanding adjuvant immunotoxicity mechanisms
Batista-Duharte, A., Lindblad, E. B., & Oviedo‐Orta, E. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2011.03.001 · Cited by 143
Pessina, A. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg188 · Cited by 142
Cationic PAMAM Dendrimers Disrupt Key Platelet Functions
Jones, C. F., Campbell, R. A., Franks, Z. G., Gibson, C. C., Thiagarajan, G., Vieira‐de‐Abreu, A., Sukavaneshvar, S., Mohammad, S., Li, D. Y., Ghandehari, H., et al. (2012) · Molecular Pharmaceutics · doi:10.1021/mp2006054 · Cited by 138
Clear and present danger? Engineered nanoparticles and the immune system
Fadeel, B. (2012) · Swiss Medical Weekly · doi:10.4414/smw.2012.13609 · Cited by 137
Merkel, O. M., Urbanics, R., Bedöcs, P., Rozsnyay, Z., Rosivall, L., Tóth, M., Kissel, T., & Szebeni, J. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.03.035 · Cited by 133
A Murine Scavenger Receptor MARCO Recognizes Polystyrene Nanoparticles
Kanno, S., Furuyama, A., & Hirano, S. (2007) · Toxicological Sciences · doi:10.1093/toxsci/kfm050 · Cited by 131
Drug withdrawals and the lessons within.
Smith, D. A., & Schmid, E. F. (2006) · PubMed · Cited by 124
Interaction of Nanoparticles with Immunocompetent Cells: Nanosafety Considerations
Boraschi, D., Costantino, L., & Italiani, P. (2011) · Nanomedicine · doi:10.2217/nnm.11.169 · Cited by 116
Bregoli, L., Chiarini, F., Gambarelli, A., Sighinolfi, G., Gatti, A. M., Santi, P., Martelli, A. M., & Cocco, L. (2009) · Toxicology · doi:10.1016/j.tox.2009.05.017 · Cited by 114
Erickson-Miller, C. L., May, R. D., Tomaszewski, J., Osborn, B., Murphy, M. J., Page, J. G., & Parchment, R. E. (1997) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050600 · Cited by 111
Macrophage Scavenger Receptor A Mediates The Uptake of Gold Colloids by Macrophages In Vitro
França, Â., Aggarwal, P., Barsov, E. V., Kozlov, S., Dobrovolskaia, M. A., & González‐Fernández, Á. (2011) · Nanomedicine · doi:10.2217/nnm.11.41 · Cited by 111
Self-citationBiocompatibility of Fe3O4@Au composite magnetic nanoparticles in vitro and in vivo
Li, Y., Liu, Zhong, Y., Zhang, D.-S., Wang, Wang, An, Y., Lin, Gao, & Zhang (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s24596 · Cited by 107
Cytokines and other immunological biomarkers in children's environmental health studies
Duramad, P., Tager, I. B., & Holland, N. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.05.017 · Cited by 104
Szebeni, J., Bedöcs, P., Urbanics, R., Bünger, R., Rosivall, L., Tóth, M., & Barenholz, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.029 · Cited by 102
Immunotoxicity of Nanoparticles
Petrarca, C., Mangifesta, R., & Giampaolo, L. D. (2020) · Current topics in environmental health and preventive medicine · doi:10.1007/978-981-15-4735-5_6 · Cited by 98
MYERSON, J., HE, L., LANZA, G., TOLLEFSEN, D., & WICKLINE, S. (2011) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2011.04339.x · Cited by 96
Increased bone marrow toxicity of doxorubicin bound to nanoparticles
Gibaud, S., Andreux, J. P., Weingarten, C., et al. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90299-2 · Cited by 89
Senn, J. J., Burel, S. A., & Henry, S. P. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.084004 · Cited by 88
Woodruff, T. J., Zeise, L. A., Axelrad, D. A., Guyton, K. Z., Janssen, S. J., Miller, M. D., Miller, G. G., Schwartz, J. M., Alexeeff, G. V., Anderson, H. A., et al. (2008) · Environmental Health Perspectives · doi:10.1289/ehp.11516 · Cited by 87
Alternative in vitro assays in nanomaterial toxicology
Hartung, T., & Sabbioni, E. (2011) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.153 · Cited by 84
Particulate Systems for Targeting of Macrophages: Basic and Therapeutic Concepts
Moghimi, S. M., Parhamifar, L., Ahmadvand, D., Wibroe, P. P., Andresen, T. L., Farhangrazi, Z. S., & Hunter, A. C. (2012) · Journal of Innate Immunity · doi:10.1159/000339153 · Cited by 79
Clinical immunotoxicity of therapeutic proteins
Descotes, J., & Gouraud, A. (2008) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802525496 · Cited by 77
Moon, E., Yi, G.-H., Kang, J. S., Lim, J., Kim, H., & Pyo, S. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.543995 · Cited by 76
Pham, C. T. N., Mitchell, L. M., Huang, J. L., Lubniewski, C. M., Schall, O. F., Killgore, J. K., Pan, D., Wickline, S. A., Lanza, G. M., & Hourcade, D. E. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.180760 · Cited by 72
Predicting hematological toxicity (myelosuppression) of cytotoxic drug therapy from in vitro tests
Parchment, R. E., Gordon, M., Grieshaber, C. K., Sessa, C., Volpe, D. A., & Ghielmini, M. E. G. (1998) · Annals of Oncology · doi:10.1023/a:1008245906772 · Cited by 72
Allard-Vannier, É., Cohen-Jonathan, S., Gautier, J., Hervé-Aubert, K., Munnier, E., Soucé, M., Legras, P., Passirani, C., & Chourpa, I. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.002 · Cited by 71
Amorphous nanosilicas induce consumptive coagulopathy after systemic exposure
Nabeshi, H., Yoshikawa, T., Matsuyama, K., Nakazato, Y., Arimori, A., Isobe, M., Tochigi, S., Kondoh, S., Hirai, T., Akase, T., et al. (2012) · Nanotechnology · doi:10.1088/0957-4484/23/4/045101 · Cited by 71
Huynh, N. T., Morille, M., Bejaud, J., Legras, P., Vessières, A., Jaouen, G., Benoît, J., & Passirani, C. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0501-y · Cited by 71
Whole blood cytokine response as a measure of immunotoxicity
Langezaal, I., Coecke, S., & Härtung, T. (2001) · Toxicology in Vitro · doi:10.1016/s0887-2333(01)00028-5 · Cited by 70
Dendrimer-Induced Leukocyte Procoagulant Activity Depends on Particle Size and Surface Charge
Dobrovolskaia, M. A., Patri, A. K., Potter, T. M., Rodriguez, J. C., Hall, J. B., & McNeil, S. E. (2011) · Nanomedicine · doi:10.2217/nnm.11.105 · Cited by 69
Self-citationImmunomodulating activities of soluble synthetic polymer-bound drugs
Říhová, B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00043-1 · Cited by 68
Schindler, S., von Aulock, S., Daneshian, M., & Hartung, T. (2009) · ALTEX · doi:10.14573/altex.2009.4.265 · Cited by 67
The Accuracy of Extended Histopathology to Detect Immunotoxic Chemicals
Germolec, D. R. (2004) · Toxicological Sciences · doi:10.1093/toxsci/kfh271 · Cited by 60
Considerations When Submitting Nanotherapeutics to FDA/CDER for Regulatory Review
Tyner, K. M., & Sadrieh, N. K. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-198-1_3 · Cited by 57
Shan, X., Yuan, Y., Liu, C., Tao, X., Sheng, Y., & Xu, F. L. (2009) · Biomedical Microdevices · doi:10.1007/s10544-009-9336-2 · Cited by 56
Assessment of pyrogenic contaminations with validated human whole-blood assay
Daneshian, M., von Aulock, S., & Härtung, T. (2009) · Nature Protocols · doi:10.1038/nprot.2009.159 · Cited by 53
Simberg, D., Zhang, W.-M., Merkulov, S. M., McCrae, K. R., Park, J., Sailor, M. J., & Ruoslahti, E. I. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.05.035 · Cited by 44
Qualitative Analysis of Total Complement Activation by Nanoparticles
Neun, B. W., & Dobrovolskaia, M. A. (2010) · Methods in molecular biology · doi:10.1007/978-1-60327-198-1_25 · Cited by 36
Self-citationIn vitro evaluation of nanoparticles spleen capture
Demoy, M., Andreux, J. P., Weingarten, C., Gouritin, B., Guilloux, V., & Couvreur, P. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00068-5 · Cited by 35
From clinical to human toxicology: linking animal research and risk assessment in man
Descotes, J. (2003) · Toxicology Letters · doi:10.1016/s0378-4274(02)00490-3 · Cited by 35
Masubuchi, N., May, R. D., & Atsumi, R. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0721 · Cited by 33
Nanoparticle Interaction with Plasma Proteins as It Relates to Biodistribution
Treuel, L., & Nienhaus, G. U. (2012) · Frontiers in nanobiomedical research · doi:10.1142/9789813140455_0001 · Cited by 29
Gao, H. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i14.2010 · Cited by 27
Immunological Properties of Engineered Nanomaterials: An Introduction
Dobrovolskaia, M. A., & McNeil, S. E. (2012) · Frontiers in nanobiomedical research · doi:10.1142/9789814390262_0001 · Cited by 27
Self-citationLaloy, J., Robert, S., Marbehant, C., Mullier, F., Mejia, J., Piret, J., Lucas, S., Châtelain, B., Dogné, J., Toussaint, O., et al. (2011) · Nanotoxicology · doi:10.3109/17435390.2011.569096 · Cited by 26
Nanoparticles and modulation of immune responses
Pantic, I. V. (2011) · Science Progress · doi:10.3184/003685011x12979697342151 · Cited by 25
In Vitro Tests for Haematotoxicity: Prediction of Drug-induced Myelosuppression by the CFU-GM Assay
Pessina, A., Albella, B., Bayo, M., Bueren, J. A., Brantom, P., Casati, S., Croera, C., Parchment, R. E., Parent‐Massin, D., Schoeters, G. E. R., et al. (2002) · Alternatives to Laboratory Animals · doi:10.1177/026119290203002s11 · Cited by 25
A Brief History of Immunotoxicology and a Review of the Pharmaceutical Guidelines
Dean, J. H. (2004) · International Journal of Toxicology · doi:10.1080/10915810490435596 · Cited by 22
High sensitivity pyrogen testing in water and dialysis solutions
Daneshian, M., Wendel, A., Härtung, T., & von Aulock, S. (2008) · Journal of Immunological Methods · doi:10.1016/j.jim.2008.03.013 · Cited by 21
Prevalidation of the Rat CFU-GM Assay for In Vitro Toxicology Applications
Pessina, A., Bonomi, A., Cavicchini, L., Albella, B., Cerrato, L., Parent‐Massin, D., Sibiril, Y., Parchment, R. E., Behrsing, H. P., Verderio, P., et al. (2010) · Alternatives to Laboratory Animals · doi:10.1177/026119291003800212 · Cited by 16
Moneta, D., Geroni, C., Valota, O., Grossi, P., de Jonge, M. J. A., Brughera, M., Colajori, E., Ghielmini, M. E. G., & Sessa, C. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00812-2 · Cited by 11
Bidirectional Interaction Between Nanoparticles and Cells of the Mononuclear Phagocytic System
Caron, W. P., Rawal, S., Song, G. K., Kumar, P., Lay, J. C., & Zamboni, W. C. (2012) · Frontiers in nanobiomedical research · doi:10.1142/9789814390262_0012 · Cited by 11
In Vitro Assays for Monitoring Nanoparticle Interaction with Components of the Immune System
Dobrovolskaia, M. A., & McNeil, S. E. (2016) · Frontiers in nanobiomedical research · doi:10.1142/9789813140431_0010 · Cited by 10
Self-citationBehrsing, H. P., Furniss, M. J., Robillard, K. A., Tomaszewski, J. E., & Parchment, R. E. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1113-7 · Cited by 3
Cited by
DLS and zeta potential – What they are and what they are not?
Bhattacharjee, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.017 · Cited by 4,702
Nanoparticle uptake: The phagocyte problem
Gustafson, H. H., Holt-Casper, D., Grainger, D. W., & Ghandehari, H. (2015) · Nano Today · doi:10.1016/j.nantod.2015.06.006 · Cited by 1,411
Hua, S., de Matos, M. B. C., Metselaar, J. M., & Storm, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00790 · Cited by 1,048
Protein Corona Fingerprinting Predicts the Cellular Interaction of Gold and Silver Nanoparticles
Walkey, C. D., Olsen, J. B., Song, F., Liu, R., Guo, H., Olsen, D. W. H., Cohen, Y., Emili, A., & Chan, W. C. W. (2014) · ACS Nano · doi:10.1021/nn406018q · Cited by 815
An assessment of the toxicity of polypropylene microplastics in human derived cells
Hwang, J., Choi, D., Han, S., Choi, J., & Hong, J. (2019) · Science of The Total Environment · doi:10.1016/j.scitotenv.2019.05.071 · Cited by 668
Metadata
- Authors
- Dobrovolskaia, M. A., & McNeil, S. E.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 172
- Issue
- 2
- Pages
- 456-466
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2072301209
- Cited by
- 309
- References
- 100
- FWCI
- 7.71
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.